512 related articles for article (PubMed ID: 30096417)
1. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
3. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
[TBL] [Abstract][Full Text] [Related]
4. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
5. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
[TBL] [Abstract][Full Text] [Related]
6. Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India.
Ghosh S; Chakraborty M; Samanta S; Sinha N; Saha S; Chattopadhyay A; Roy SS; Bhattacharyya M
Ann Hematol; 2021 Feb; 100(2):395-403. PubMed ID: 33140134
[TBL] [Abstract][Full Text] [Related]
7. Invasive bacterial infections in a pediatric oncology unit in a tertiary care center.
Trehan A; Totadri S; Gautam V; Bansal D; Ray P
Indian J Cancer; 2014; 51(4):428-31. PubMed ID: 26842149
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
Wang L; Wang Y; Fan X; Tang W; Hu J
Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
[TBL] [Abstract][Full Text] [Related]
9. Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.
Nouér SA; Nucci M; Anaissie E
Expert Rev Hematol; 2015 Oct; 8(5):647-58. PubMed ID: 26115679
[TBL] [Abstract][Full Text] [Related]
10. Bacteremia in febrile cancer patients in Uganda.
Lubwama M; Phipps W; Najjuka CF; Kajumbula H; Ddungu H; Kambugu JB; Bwanga F
BMC Res Notes; 2019 Jul; 12(1):464. PubMed ID: 31362783
[TBL] [Abstract][Full Text] [Related]
11. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.
Oriol I; Sabé N; Simonetti AF; Lladó L; Manonelles A; González J; Tubau F; Carratalà J
Transpl Int; 2017 Sep; 30(9):903-913. PubMed ID: 28500792
[TBL] [Abstract][Full Text] [Related]
12. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Clerici D; Oltolini C; Greco R; Ripa M; Giglio F; Mastaglio S; Lorentino F; Pavesi F; Farina F; Liberatore C; Castiglion B; Tassan Din C; Bernardi M; Corti C; Peccatori J; Scarpellini P; Ciceri F; Castagna A
Int J Antimicrob Agents; 2021 Jun; 57(6):106335. PubMed ID: 33838223
[TBL] [Abstract][Full Text] [Related]
13. Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli.
Falcone M; Tiseo G; Dentali F; La Regina M; Foglia E; Gambacorta M; Garagiola E; Bonardi G; Clerici P; Colombo F; Farcomeni A; Concia E; Corrao S; Campanini M; Mazzone A
Eur J Intern Med; 2018 Jul; 53():21-28. PubMed ID: 29426676
[TBL] [Abstract][Full Text] [Related]
14. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
15. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
Irfan S; Idrees F; Mehraj V; Habib F; Adil S; Hasan R
BMC Infect Dis; 2008 Jun; 8():80. PubMed ID: 18541017
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum procalcitonin predicts Gram-negative bloodstream infections in patients with burns.
Lin JC; Chen ZH; Chen XD
Burns; 2020 Feb; 46(1):182-189. PubMed ID: 31859083
[TBL] [Abstract][Full Text] [Related]
17. An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.
Kara Ali R; Surme S; Balkan II; Salihoglu A; Sahin Ozdemir M; Ozdemir Y; Mete B; Can G; Ar MC; Tabak F; Saltoglu N
Ann Hematol; 2020 Aug; 99(8):1925-1932. PubMed ID: 32564194
[TBL] [Abstract][Full Text] [Related]
18. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
Raad C; Behdenna A; Fuhrmann C; Conter C; Cuzzubbo D; Rasigade JP; Bertrand Y; Domenech C
Eur J Pediatr; 2021 Sep; 180(9):2921-2930. PubMed ID: 33835249
[TBL] [Abstract][Full Text] [Related]
19. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia.
Palmer HR; Palavecino EL; Johnson JW; Ohl CA; Williamson JC
Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):955-9. PubMed ID: 23397233
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study.
Al-Tawfiq JA; Hinedi K; Khairallah H; Saadeh B; Abbasi S; Noureen M; Raza S; Alkhatti A
J Infect Public Health; 2019; 12(3):364-366. PubMed ID: 30594483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
